| Product NDC: | 59630-710 |
| Proprietary Name: | Orapred |
| Non Proprietary Name: | prednisolone sodium phosphate |
| Active Ingredient(s): | 15 mg/5mL & nbsp; prednisolone sodium phosphate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 59630-710 |
| Labeler Name: | Shionogi Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075117 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20001214 |
| Package NDC: | 59630-710-10 |
| Package Description: | 10 BOTTLE, GLASS in 1 PACKAGE (59630-710-10) > 20 mL in 1 BOTTLE, GLASS |
| NDC Code | 59630-710-10 |
| Proprietary Name | Orapred |
| Package Description | 10 BOTTLE, GLASS in 1 PACKAGE (59630-710-10) > 20 mL in 1 BOTTLE, GLASS |
| Product NDC | 59630-710 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | prednisolone sodium phosphate |
| Dosage Form Name | SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20001214 |
| Marketing Category Name | ANDA |
| Labeler Name | Shionogi Inc. |
| Substance Name | PREDNISOLONE SODIUM PHOSPHATE |
| Strength Number | 15 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |